Recent News

Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30
Program here.
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, .
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici.
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici.
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo.
Le CERIMED obtient la double certification ISO 9001:2015 et NF X50-900:2016 pour ses activités de prestation et d’innovation radiologiques et nucléaires pré-cliniques
Le Centre Européen de Recherche en Imagerie Médicale (CERIMED, UMS AMU CNRS 2012) a obtenu le 5 juin 2022 la double certification ISO 9001:2015 et NF-X50-900:2016 pour
Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”
Program here.
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility

Last Publications (10/366)

Connell, E, Gerard, É, Oules, B, Brunet-Possenti, F, Lamoureux, A, Bonnefille, H et al.. Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma. Oncologist. 2024; :. doi: 10.1093/oncolo/oyae085. PubMed PMID:38761384 .
Hourcau, G, Taïeb, D. Comment on: Is work overload associated with diagnostic errors on [¹⁸F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06753-3. PubMed PMID:38743134 .
Pepponi, M, Berti, V, Fasciglione, E, Montanini, F, Canu, L, Hubele, F et al.. [⁶⁸Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06735-5. PubMed PMID:38687372 .
Van Weehaeghe, D, Lapauw, B, Fraioli, F, Cecchin, D, Verger, A, Guedj, E et al.. EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06728-4. PubMed PMID:38687371 .
Dubois, J, Tosato, G, Garrigue, P, Taieb, D, Guillet, B, Nail, V et al.. Short-Term Biological Toxicity Prediction of [¹⁷⁷Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis. Cancer Biother Radiopharm. 2024; :. doi: 10.1089/cbr.2023.0195. PubMed PMID:38655905 .
Baylot, V, Le, TK, Taïeb, D, Rocchi, P, Colleaux, L. Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs. Commun Biol. 2024;7 (1):489. doi: 10.1038/s42003-024-06121-9. PubMed PMID:38653753 PubMed Central PMC11039704.
Jha, A, Patel, M, Ling, A, Shah, R, Chen, CC, Millo, C et al.. Diagnostic performance of [⁶⁸Ga]DOTATATE PET/CT, [¹⁸F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma. Eur Radiol. 2024; :. doi: 10.1007/s00330-024-10652-4. PubMed PMID:38625612 .
Muller, R, Cauchois, R, Lagarde, M, Roffino, S, Genovesio, C, Fernandez, S et al.. Mortality, cardiac and cerebral damages reduction by IL-1 inhibition in a murine model of TTP. Blood. 2024; :. doi: 10.1182/blood.2023021974. PubMed PMID:38598839 .
Horowitz, T, Guedj, E, Eusebio, A, Fluchère, F, Azulay, JP, Delmont, E et al.. Molecular Imaging in CANVAS: A Contribution for Differential Diagnosis?. Mov Disord Clin Pract. 2024; :. doi: 10.1002/mdc3.14041. PubMed PMID:38576115 .
Vidal, V, Bargellini, I, Bent, C, Kee, S, Little, M, O’Sullivan, G et al.. Performance Evaluation of a Miniature and Disposable Endovascular Robotic Device. Cardiovasc Intervent Radiol. 2024;47 (4):503-507. doi: 10.1007/s00270-024-03686-0. PubMed PMID:38512351 .

Search PubMed

Dernières Publications (10/366)

Connell, E, Gerard, É, Oules, B, Brunet-Possenti, F, Lamoureux, A, Bonnefille, H et al.. Molecularly matched targeted therapy: a promising approach for refractory metastatic melanoma. Oncologist. 2024; :. doi: 10.1093/oncolo/oyae085. PubMed PMID:38761384 .
Hourcau, G, Taïeb, D. Comment on: Is work overload associated with diagnostic errors on [¹⁸F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06753-3. PubMed PMID:38743134 .
Pepponi, M, Berti, V, Fasciglione, E, Montanini, F, Canu, L, Hubele, F et al.. [⁶⁸Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06735-5. PubMed PMID:38687372 .
Van Weehaeghe, D, Lapauw, B, Fraioli, F, Cecchin, D, Verger, A, Guedj, E et al.. EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2024; :. doi: 10.1007/s00259-024-06728-4. PubMed PMID:38687371 .
Dubois, J, Tosato, G, Garrigue, P, Taieb, D, Guillet, B, Nail, V et al.. Short-Term Biological Toxicity Prediction of [¹⁷⁷Lu]Lutetium-Oxodotreotide: An Original Retrospective Analysis. Cancer Biother Radiopharm. 2024; :. doi: 10.1089/cbr.2023.0195. PubMed PMID:38655905 .
Baylot, V, Le, TK, Taïeb, D, Rocchi, P, Colleaux, L. Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs. Commun Biol. 2024;7 (1):489. doi: 10.1038/s42003-024-06121-9. PubMed PMID:38653753 PubMed Central PMC11039704.
Jha, A, Patel, M, Ling, A, Shah, R, Chen, CC, Millo, C et al.. Diagnostic performance of [⁶⁸Ga]DOTATATE PET/CT, [¹⁸F]FDG PET/CT, MRI of the spine, and whole-body diagnostic CT and MRI in the detection of spinal bone metastases associated with pheochromocytoma and paraganglioma. Eur Radiol. 2024; :. doi: 10.1007/s00330-024-10652-4. PubMed PMID:38625612 .
Muller, R, Cauchois, R, Lagarde, M, Roffino, S, Genovesio, C, Fernandez, S et al.. Mortality, cardiac and cerebral damages reduction by IL-1 inhibition in a murine model of TTP. Blood. 2024; :. doi: 10.1182/blood.2023021974. PubMed PMID:38598839 .
Horowitz, T, Guedj, E, Eusebio, A, Fluchère, F, Azulay, JP, Delmont, E et al.. Molecular Imaging in CANVAS: A Contribution for Differential Diagnosis?. Mov Disord Clin Pract. 2024; :. doi: 10.1002/mdc3.14041. PubMed PMID:38576115 .
Vidal, V, Bargellini, I, Bent, C, Kee, S, Little, M, O’Sullivan, G et al.. Performance Evaluation of a Miniature and Disposable Endovascular Robotic Device. Cardiovasc Intervent Radiol. 2024;47 (4):503-507. doi: 10.1007/s00270-024-03686-0. PubMed PMID:38512351 .

Search PubMed